Observations on patents and other IP from a dual-licensed practitioner
In 1995, the USA moved to a 20-years-from-earliest-filing-date regime. A few years later, in response to complaints that this effectively foreshortened patent term from the previous 17-years-from-grant if the USPTO…
As I mentioned yesterday, the Minister of Health signed an order this week allowing the state to import generic Kaletra (a combination of lopinavir and ritonavir) to be used, potentially,…
Subject matter eligibility under 35 USC §101, and the requirements for compliance with the written description and enablement requirements of 35 USC §112, have been areas of rapid legal development…
There’s a deadline approaching in a case I filed in Israel for a US colleague. Over the years I’ve handled a number of Israel filings for this person, and although…
Last month the ILPTO published final versions of two circular notices; the drafts of these notices were discussed at length here, here, here, here and here. The final versions aren’t…
That's a famous line from Mel Brooks' "History of the World", ostensibly uttered by Louis XVI, but on the basis of recently-issued US 9,119,029, it would seem to true of Google…
As of last night a fair number of comments had been submitted to the USPTO about its examination guidelines under Myriad. My two cents are here Download Comments on Myriad…
If you're going to sue someone for infringement, it's a good idea before filing suit to make sure that you've got at least a colorable argument that your claims cover…
A substantive post on the more notable aspects of last week’s amendments to the Israel patent statute is in progress, but at least one point bears separate discussion: the abolishment…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.